Finally, we demonstrated that the transcriptional and translational levels of ANXA2 and KRT17 are also modulated, suggesting an interplay between both the proteins in NAFLD and opening a new path in understanding the molecular mechanisms underlying the pathogenesis of the disease. This evidence concerns the gene ANXA2 and metabolic dysfunction-associated steatotic liver disease.